Interplay between inflammatory tumor microenvironment and cancer stem cells (Review)
- Authors:
- Shijian Zhang
- Xi Yang
- Lei Wang
- Chenping Zhang
-
Affiliations: Department of Oral and Maxillofacial‑Head and Neck Oncology, Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200011, P.R. China - Published online on: May 16, 2018 https://doi.org/10.3892/ol.2018.8716
- Pages: 679-686
This article is mentioned in:
Abstract
 |
 |
|
Bonnet D and Dick JE: Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med. 3:730–737. 1997. View Article : Google Scholar : PubMed/NCBI | |
|
Albini A, Bruno A, Gallo C, Pajardi G, Noonan DM and Dallaglio K: Cancer stem cells and the tumor microenvironment: Interplay in tumor heterogeneity. Connect Tissue Res. 56:414–425. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Voog J and Jones DL: Stem cells and the niche: A dynamic duo. Cell Stem Cell. 6:103–115. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Kise K, Kinugasa-Katayama Y and Takakura N: Tumor microenvironment for cancer stem cells. Adv Drug Deliv Rev. 99:197–205. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Elinav E, Nowarski R, Thaiss CA, Hu B, Jin C and Flavell RA: Inflammation-induced cancer: Crosstalk between tumours, immune cells and microorganisms. Nat Rev Cancer. 13:759–771. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Corrales L and Gajewski TF: Molecular pathways: Targeting the stimulator of interferon genes (STING) in the immunotherapy of cancer. Clin Cancer Res. 21:4774–4779. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Trinchieri G: Type I interferon: Friend or foe? J Exp Med. 207:2053–2063. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Zaidi MR and Merlino G: The two faces of interferon-γ in cancer. Clin Cancer Res. 17:6118–6124. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Nardi Beyer N and da Silva Meirelles L: Mesenchymal stem cells: Isolation, in vitro expansion and characterization. Handb Exp Pharmacol. 249–282. 2006. View Article : Google Scholar | |
|
Shi S and Gronthos S: Perivascular niche of postnatal mesenchymal stem cells in human bone marrow and dental pulp. J Bone Miner Res. 18:696–704. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Sharma RR, Pollock K, Hubel A and Mckenna D: Mesenchymal stem or stromal cells: A review of clinical applications and manufacturing practices. Transfusion. 54:1418–1437. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Wang L, Zhao Y, Liu Y, Akiyama K, Chen C, Qu C, Jin Y and Shi S: IFN-γ and TNF-α synergistically induce mesenchymal stem cell impairment and tumorigenesis via NFκB signaling. Stem Cells. 31:1383–1395. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Liu Y, Wang L, Kikuiri T, Akiyama K, Chen C, Xu X, Yang R, Chen W, Wang S and Shi S: Mesenchymal stem cell-based tissue regeneration is governed by recipient T lymphocytes via IFN-γ and TNF-α. Nat Med. 17:1594–1601. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Trivanović D, Jauković A, Krstić J, Nikolić S, Okić Djordjević I, Kukolj T, Obradović H, Mojsilović S, Ilić V, Santibanez JF and Bugarski D: Inflammatory cytokines prime adipose tissue mesenchymal stem cells to enhance malignancy of MCF-7 breast cancer cells via transforming growth factor-β1. IUBMB Life. 68:190–200. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Lv N, Gao Y, Guan H, Wu D, Ding S, Teng W and Shan Z: Inflammatory mediators, tumor necrosis factor-α and interferon-γ, induce EMT in human PTC cell lines. Oncol Lett. 10:2591–2597. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Schürch C, Riether C, Amrein MA and Ochsenbein AF: Cytotoxic T cells induce proliferation of chronic myeloid leukemia stem cells by secreting interferon-γ. J Exp Med. 210:605–621. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Zhu Y, Karakhanova S, Huang X, Deng SP, Werner J and Bazhin AV: Influence of interferon-α on the expression of the cancer stem cell markers in pancreatic carcinoma cells. Exp Cell Res. 324:146–156. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Yamashina T, Baghdadi M, Yoneda A, Kinoshita I, Suzu S, Dosakaakita H and Jinushi M: Cancer stem-like cells derived from chemoresistant tumors have a unique capacity to prime tumorigenic myeloid cells. Cancer Res. 74:2698–2709. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Jin X, Kim SH, Jeon HM, Beck S, Sohn YW, Yin J, Kim JK, Lim YC, Lee JH, Kim SH, et al: Interferon regulatory factor 7 regulates glioma stem cells via interleukin-6 and Notch signalling. Brain. 135:1055–1069. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Ojha R, Singh SK and Bhattacharyya S: JAK-mediated autophagy regulates stemness and cell survival in cisplatin resistant bladder cancer cells. Biochim Biophys Acta. 1860:2484–2497. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Li J, Chen JN, Zeng TT, He F, Chen SP, Ma S, Bi J, Zhu XF and Guan XY: CD133+ liver cancer stem cells resist interferon-gamma-induced autophagy. BMC Cancer. 16:152016. View Article : Google Scholar : PubMed/NCBI | |
|
Furuta J, Inozume T, Harada K and Shimada S: CD271 on melanoma cell is an IFN-γ-inducible immunosuppressive factor that mediates downregulation of melanoma antigens. J Invest Dermatol. 134:1369–1377. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Kharma B, Baba T, Matsumura N, Kang HS, Hamanishi J, Murakami R, McConechy MM, Leung S, Yamaguchi K, Hosoe Y, et al: STAT1 drives tumor progression in serous papillary endometrial cancer. Cancer Res. 74:6519–6530. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Wang AM, Creasey AA, Ladner MB, Lin LS, Strickler J, Van Arsdell JN, Yamamoto R and Mark DF: Molecular cloning of the complementary DNA for human tumor necrosis factor. Science. 228:149–154. 1985. View Article : Google Scholar : PubMed/NCBI | |
|
Roberts NJ, Zhou S, Diaz LA and Matthias H: Systemic use of tumor necrosis factor alpha as an anticancer agent. Oncotarget. 2:739–751. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang L, Jiao M, Wu K, Li L, Zhu G, Wang X, He D and Wu D: TNF-α induced epithelial mesenchymal transition increases stemness properties in renal cell carcinoma cells. Int J Clin Exp Med. 7:4951–4958. 2014.PubMed/NCBI | |
|
Techasen A, Namwat N, Loilome W, Bungkanjana P, Khuntikeo N, Puapairoj A, Jearanaikoon P, Saya H and Yongvanit P: Tumor necrosis factor-α (TNF-α) stimulates the epithelial-mesenchymal transition regulator Snail in cholangiocarcinoma. Med Oncol. 29:3083–3091. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Valizadeh A, Ahmadzadeh A, Saki G, Khodadadi A and Teimoori A: Role of tumor necrosis factor-producing mesenchymal stem cells on apoptosis of chronic B-lymphocytic tumor cells resistant to fludarabine-based chemotherapy. Asian Pac J Cancer Prev. 16:8533–8539. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Yu PF, Huang Y, Han YY, Lin LY, Sun WH, Rabson AB, Wang Y and Shi YF: TNFα-activated mesenchymal stromal cells promote breast cancer metastasis by recruiting CXCR2+ neutrophils. Oncogene. 36:482–490. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Katanov C, Lerrer S, Liubomirski Y, Leider-Trejo L, Meshel T, Bar J, Feniger-Barish R, Kamer I, Soria-Artzi G, Kahani H, et al: Regulation of the inflammatory profile of stromal cells in human breast cancer: Prominent roles for TNF-α and the NF-κB pathway. Stem Cell Res Ther. 6:872015. View Article : Google Scholar : PubMed/NCBI | |
|
Lee SH, Hong HS, Liu ZX, Kim RH, Kang MK, Park NH and Shin KH: TNFα enhances cancer stem cell-like phenotype via Notch-Hes1 activation in oral squamous cell carcinoma cells. Biochem Biophys Res Commun. 424:58–64. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Storci G, Sansone P, Mari S, D'Uva G, Tavolari S, Guarnieri T, Taffurelli M, Ceccarelli C, Santini D, Chieco P, et al: TNFalpha up-regulates SLUG via the NF-kappaB/HIF1alpha axis, which imparts breast cancer cells with a stem cell-like phenotype. J Cell Physiol. 225:682–691. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Ostyn P, El Machhour R, Begard S, Kotecki N, Vandomme J, Flamenco P, Segard P, Masselot B, Formstecher P, Touil Y and Polakowska R: Transient TNF regulates the self-renewing capacity of stem-like label-retaining cells in sphere and skin equivalent models of melanoma. Cell Commun Signal. 12:522014. View Article : Google Scholar : PubMed/NCBI | |
|
Fukushima K, Tsuchiya K, Kano Y, Horita N, Hibiya S, Hayashi R, Kitagaki K, Negi M, Itoh E, Akashi T, et al: Atonal homolog 1 protein stabilized by tumor necrosis factor α induces high malignant potential in colon cancer cell line. Cancer Sci. 106:1000–1007. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Gallipoli P, Pellicano F, Morrison H, Laidlaw K, Allan EK, Bhatia R, Copland M, Jørgensen HG and Holyoake TL: Autocrine TNF-α production supports CML stem and progenitor cell survival and enhances their proliferation. Blood. 122:3335–3339. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Zhou X, Zhou S, Li B, Li Q, Gao L, Li D, Gong Q, Zhu L, Wang J, Wang N, et al: Transmembrane TNF-α preferentially expressed by leukemia stem cells and blasts is a potent target for antibody therapy. Blood. 126:1433–1442. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Sheng YH, He Y, Hasnain SZ, Wang R, Tong H, Clarke DT, Lourie R, Oancea I, Wong KY, Lumley JW, et al: MUC13 protects colorectal cancer cells from death by activating the NF-κB pathway and is a potential therapeutic target. Oncogene. 36:700–713. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Nenu I, Tudor D, Filip AG and Baldea I: Current position of TNF-α in melanomagenesis. Tumor Biol. 36:6589–6602. 2015. View Article : Google Scholar | |
|
Bromberg J and Wang TC: Inflammation and cancer: IL-6 and STAT3 complete the link. Cancer Cell. 15:79–80. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Smith PC, Hobisch A, Lin DL, Culig Z and Keller ET: Interleukin-6 and prostate cancer progression. Cytokine Growth Factor Rev. 12:33–40. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Yao X, Huang J, Zhong H, Shen N, Faggioni R, Fung M and Yao Y: Targeting interleukin-6 in inflammatory autoimmune diseases and cancers. Pharmacol Ther. 141:125–139. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Hideshima T, Nakamura N, Chauhan D and Anderson KC: Biologic sequelae of interleukin-6 induced PI3-K/Akt signaling in multiple myeloma. Oncogene. 20:5991–6000. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Kumari N, Dwarakanath BS, Das A and Bhatt AN: Role of interleukin-6 in cancer progression and therapeutic resistance. Tumor Biol. 37:11553–11572. 2016. View Article : Google Scholar | |
|
Chen Y, Zhang F, Tsai Y, Yang X, Yang L, Duan S, Wang X, Keng P and Lee SO: IL-6 signaling promotes DNA repair and prevents apoptosis in CD133+ stem-like cells of lung cancer after radiation. Radiat Oncol. 10:2272015. View Article : Google Scholar : PubMed/NCBI | |
|
Altundag O, Altundag K and Gunduz E: Interleukin-6 and C-reactive protein in metastatic renal cell carcinoma. J Clin Oncol. 23:1044–1045. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Knüpfer H and Preiß R: Significance of interleukin-6 (IL-6) in breast cancer (review). Breast Cancer Res Treat. 102:129–135. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Ok LS, Yang X, Duan S, Ying T, Strojny LR, Peter K, et al: IL-6 promotes growth and epithelial-mesenchymal transition of CD133+ cells of non-small cell lung cancer. Oncotarget. 7:6626–6638. 2016.PubMed/NCBI | |
|
Zhang F, Duan S, Ying T, Keng PC and Chen Y, Lee SO and Chen Y: Cisplatin treatment increases stemness through upregulation of hypoxia-inducible factors by interleukin-6 in non-small cell lung cancer. Cancer Sci. 107:746–754. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Liu CC, Lin JH, Hsu TW, Su K, Li AF, Hsu HS and Hung SC: IL-6 enriched lung cancer stem-like cell population by inhibition of cell cycle regulators via DNMT1 upregulation. Int J Cancer. 136:547–559. 2015.PubMed/NCBI | |
|
Hsu HS, Lin JH, Hsu TW, Su K, Wang CW, Yang KY, Chiou SH and Hung SC: Mesenchymal stem cells enhance lung cancer initiation through activation of IL-6/JAK2/STAT3 pathway. Lung Cancer. 75:167–177. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Lu JH, Wei HJ, Peng BY, Chou HH, Chen WH, Liu HY and Deng WP: Adipose-derived stem cells enhance cancer stem cell property and tumor formation capacity in lewis lung carcinoma cells through an interleukin-6 paracrine circuit. Stem Cells Dev. 25:1833–1842. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
a Dzaye OD, Hu F, Derkow K, Haage V, Euskirchen P, Harms C, Lehnardt S, Synowitz M, Wolf SA and Kettenmann H: Glioma stem cells but not bulk glioma cells upregulate IL-6 secretion in microglia/brain macrophages via toll-like receptor 4 signaling. J Neuropathol Exp Neurol. 75:429–440. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Ding DC, Liu HW and Chu TY: Interleukin-6 from ovarian mesenchymal stem cells promotes proliferation, sphere and colony formation and tumorigenesis of an ovarian cancer cell line SKOV3. J Cancer. 7:1815–1823. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Huynh PT, Beswick EJ, Yun AC, Johnson P, O'Connell MR, Watts T, Singh P, Qiu S, Morris K, Powell DW and Pinchuk IV: CD90(+) stromal cells are the major source of IL-6, which supports cancer stem-like cells and inflammation in colorectal cancer. Int J Cancer. 138:1971–1981. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Wang X, Sun W, Shen W, Xia M, Chen C, Xiang D, Ning B, Cui X, Li H, Li X, et al: Long non-coding RNA DILC regulates liver cancer stem cells via IL-6/STAT3 axis. J Hepatol. 64:1283–1294. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Mcnee G, Eales KL, Wei W, Williams DS, Barkhuizen A, Bartlett DB, Essex S, Anandram S, Filer A, Moss PA, et al: Citrullination of histone H3 drives IL-6 production by bone marrow mesenchymal stem cells in MGUS and multiple myeloma. Leukemia. 31:373–381. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Kolls JK and Lindén A: Interleukin-17 family members and inflammation. Immunity. 21:467–476. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Guéry L and Hugues S: Th17 cell plasticity and functions in cancer immunity. Biomed Res Int. 2015:3146202015. View Article : Google Scholar : PubMed/NCBI | |
|
Yang B, Fung A, Zhao H, Wang T and Ma D: The Role of Interleukin 17 in Tumour Proliferation, Angiogenesis and Metastasis. Mediators of Inflammation. 2014:390–392. 2014. View Article : Google Scholar | |
|
Yang S, Wang B, Guan C, Wu B, Cai C, Wang M, Zhang B, Liu T and Yang P: Foxp3+IL-17+ T cells promote development of cancer-initiating cells in colorectal cancer. J Leukoc Biol. 89:85–91. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Wei S, Zhao E, Kryczek I and Zou W: Th17 cells have stem cell-like features and promote long-term immunity. Oncoimmunology. 1:516–519. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Lotti F, Jarrar AM, Pai RK, Hitomi M, Lathia J, Mace A, Gantt GA Jr, Sukhdeo K, DeVecchio J, Vasanji A, et al: Chemotherapy activates cancer-associated fibroblasts to maintain colorectal cancer-initiating cells by IL-17A. J Exp Med. 210:2851–2872. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Xiang T, Long H, He L, Han X, Lin K, Liang Z, Zhuo W, Xie R and Zhu B: Interleukin-17 produced by tumor microenvironment promotes self-renewal of CD133+ cancer stem-like cells in ovarian cancer. Oncogene. 34:165–176. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Luo Y, Yang Z, Su L, Shan J, Xu H, Xu Y, Liu L, Zhu W, Chen X, Liu C, et al: Non-CSCs nourish CSCs through interleukin-17E-mediated activation of NF-κB and JAK/STAT3 signaling in human hepatocellular carcinoma. Cancer Lett. 375:390–399. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Parajuli P, Anand R, Mandalaparty C, Suryadevara R, Sriranga PU, Michelhaugh SK, Cazacu S, Finniss S, Thakur A, Lum LG, et al: Preferential expression of functional IL-17R in glioma stem cells: Potential role in self-renewal. Oncotarget. 7:6121–6135. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Jiang YX, Yang SW, Li PA, Luo X, Li ZY, Hao YX and Yu PW: The promotion of the transformation of quiescent gastric cancer stem cells by IL-17 and the underlying mechanisms. Oncogene. 36:1256–1264. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Gabrilovich DI and Nagaraj S: Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol. 9:162–174. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Condamine T and Gabrilovich DI: Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function. Trends Immunol. 32:19–25. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Medina-Echeverz J, Aranda F and Berraondo P: Myeloid-derived cells are key targets of tumor immunotherapy. Oncoimmunology. 3:e283982014. View Article : Google Scholar : PubMed/NCBI | |
|
Chikamatsu K, Okamoto A, Sakakura K, Hatsushika K, Takahashi G and Masuyama K: P3.14. Immunoregulatory properties of CD44+ cancer stem-like cells in squamous cell carcinoma of the head and neck. Oral Oncol Suppl. 3:205–206. 2009. View Article : Google Scholar | |
|
Otvos B, Finke J, Vogelbaum M and Lathia JD: Interrogating the interactions between myeloid derived suppressor cells and cancer stem cells in glioblastoma. J Immuno Ther Cancer. 1:2682013. View Article : Google Scholar | |
|
Gao L, Yu S and Zhang X: Hypothesis: Tim-3/galectin-9, a new pathway for leukemia stem cells survival by promoting expansion of myeloid-derived suppressor cells and differentiating into tumor-associated macrophages. Cell Biochem Biophys. 70:273–277. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Otvos B, Silver DJ, Mulkearns-Hubert EE, Alvarado AG, Turaga SM, Sorensen MD, Rayman P, Flavahan WA, Hale JS, Stoltz K, et al: Cancer stem cell-secreted macrophage migration inhibitory factor stimulates myeloid derived suppressor cell function and facilitates glioblastoma immune evasion. Stem Cells. 34:2026–2039. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Cui TX, Kryczek I, Zhao L, Zhao E, Kuick R, Roh MH, Vatan L, Szeliga W, Mao Y, Thomas DG, et al: Myeloid-derived suppressor cells enhance stemness of cancer cells by inducing microRNA101 and suppressing the corepressor CtBP2. Immunity. 39:611–621. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Panni RZ, Sanford DE, Belt BA, Mitchem JB, Worley LA, Goetz BD, Mukherjee P, Wang-Gillam A, Link DC, Denardo DG, et al: Tumor-induced STAT3 activation in monocytic myeloid-derived suppressor cells enhances stemness and mesenchymal properties in human pancreatic cancer. Cancer Immunol Immunother. 63:513–528. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Peng D, Tanikawa T, Li W, Zhao L, Vatan L, Szeliga W, Wan S, Wei S, Wang Y, Liu Y, et al: Myeloid-derived suppressor cells endow stem-like qualities to breast cancer cells through IL6/STAT3 and NO/NOTCH cross-talk signaling. Cancer Res. 76:3156–3165. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Shih JY, Yuan A, Chen JW and Yang PC: Tumor-associated macrophage: Its role in cancer invasion and metastasis. J Cancer Mol. 2:101–106. 2006. | |
|
Allavena P, Sica A, Solinas G, Porta C and Mantovani A: The inflammatory micro-environment in tumor progression: The role of tumor-associated macrophages. Crit Rev Oncol Hematol. 66:1–9. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Franklin RA, Liao W, Sarkar A, Kim MV, Bivona MR, Liu K, Pamer EG and Li MO: The cellular and molecular origin of tumor-associated macrophages. Science. 344:921–925. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Raggi C, Mousa HS, Correnti M, Sica A and Invernizzi P: Cancer stem cells and tumor-associated macrophages: A roadmap for multitargeting strategies. Oncogene. 35:671–682. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Jinushi M, Chiba S, Yoshiyama H, Masutomi K, Kinoshita I, Dosaka-Akita H, Yagita H, Takaoka A and Tahara H: Tumor-associated macrophages regulate tumorigenicity and anticancer drug responses of cancer stem/initiating cells. Proc Natl Acad Sci USA. 108:12425–12430. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Ding J, Jin W, Chen C, Shao Z and Wu J: Tumor associated macrophage × cancer cell hybrids may acquire cancer stem cell properties in breast cancer. PLoS One. 7:e419422012. View Article : Google Scholar : PubMed/NCBI | |
|
Ye XZ, Xu SL, Xin YH, Yu SC, Ping YF, Chen L, Xiao HL, Wang B, Yi L, Wang QL, et al: Tumor-associated microglia/macrophages enhance the invasion of glioma stem-like cells via TGF-β1 signaling pathway. J Immunol. 189:444–453. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Fan QM, Jing YY, Yu GF, Kou XR, Ye F, Gao L, Li R, Zhao QD, Yang Y, Lu ZH and Wei LX: Tumor-associated macrophages promote cancer stem cell-like properties via transforming growth factor-beta1-induced epithelial-mesenchymal transition in hepatocellular carcinoma. Cancer Lett. 352:160–168. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Yang J, Liao D, Chen C, Liu Y, Chuang TH, Xiang R, Markowitz D, Reisfeld RA and Luo Y: Tumor-associated macrophages regulate murine breast cancer stem cells through a novel paracrine EGFR/Stat3/Sox-2 signaling pathway. Stem Cells. 31:248–258. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Zhou N, Zhang Y, Zhang X, Lei Z, Hu R, Li H, Mao Y, Wang X, Irwin DM, Niu G and Tan H: Exposure of tumor-associated macrophages to apoptotic MCF-7 cells promotes breast cancer growth and metastasis. Int J Mol Sci. 16:11966–11982. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Wan S, Zhao E, Kryczek I, Vatan L, Sadovskaya A, Ludema G, Simeone DM, Zou W and Welling TH: Tumor-associated macrophages produce interleukin 6 and signal via STAT3 to promote expansion of human hepatocellular carcinoma stem cells. Gastroenterology. 147:1393–1404. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Tham M, Tan KW, Keeble J, Wang X, Hubert S, Barron L, Tan NS, Kato M, Prevost-Blondel A, Angeli V and Abastado JP: Melanoma-initiating cells exploit M2 macrophage TGFβ and arginase pathway for survival and proliferation. Oncotarget. 5:12027–12042. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Zhou W, Ke SQ, Huang Z, Flavahan W, Fang X, Paul J, Wu L, Sloan AE, McLendon RE, Li X, et al: Periostin secreted by glioblastoma stem cells recruits M2 tumour-associated macrophages and promotes malignant growth. Nat Cell Biol. 17:170–182. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Shi Y, Ping Y, Zhang X and Bian XW: Hostile takeover: Glioma stem cells recruit TAMs to support tumor progression. Cell Stem Cell. 16:219–220. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
He KF, Zhang L, Huang CF, Ma SR, Wang YF, Wang WM, Zhao ZL, Liu B, Zhao YF, Zhang WF and Sun ZJ: CD163+ tumor-associated macrophages correlated with poor prognosis and cancer stem cells in oral squamous cell carcinoma. Biomed Res Int. 2014:8386322014. View Article : Google Scholar : PubMed/NCBI | |
|
Hou YC, Chao YJ, Tung HL, Wang HC and Shan YS: Coexpression of CD44-positive/CD133-positive cancer stem cells and CD204-positive tumor-associated macrophages is a predictor of survival in pancreatic ductal adenocarcinoma. Cancer. 120:2766–2777. 2014. View Article : Google Scholar : PubMed/NCBI |
